PB8.F Phibro Animal Health Corporation

Healthcare Pharmaceuticals Frankfurt Exchange
60.41 EUR
Close of Nov 13, 2026
24.12 49.64
Market cap
EUR 1.27B
P/E
14.5x
P/B
3.34x
ROE
28.3%
Dividend yield
1.40%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is PB8.F undervalued?

Graham number
Price60.41
Graham value41.10
Premium47.0%

PB8.F trades 47.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Phibro Animal Health Corporation fundamental analysis

No fundamental analysis for Phibro Animal Health Corporation yet.

Phibro Animal Health Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers anima…

Full company profile